[Practicality of cardiovascular risk functions]

Jaume Marrugat1, Roberto Elosua2, Gloria Icaza3

  • 1Grupo de Epidemiología y Genética Cardiovascular, Instituto Hospital del Mar de Investigaciones Médicas, Barcelona, Cataluña, España. Address: Instituto Hospital del Mar de Investigaciones Médicas, Doctor Aiguader 88, Barcelona, Cataluña, España.

Medwave
|January 6, 2017
PubMed

Insights

Improving cardiovascular disease prevention requires better risk assessment. Current risk functions identify high-risk individuals for coronary artery disease, guiding targeted interventions and enhancing patient motivation for lifestyle changes.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Informatics

Background:

  • Cardiovascular disease prevention strategies need enhancement due to slow incidence reduction.
  • Existing risk functions use classical factors (age, sex, smoking, diabetes, blood pressure, lipids) for population screening, primarily for coronary artery disease.
  • These functions are crucial for primary prevention clinical guidelines, stratifying patients to optimize therapeutic efforts.

Purpose of the Study:

  • To refine cardiovascular disease prevention strategies by improving risk assessment.
  • To highlight the importance of accurate coronary artery disease risk stratification for targeted interventions.
  • To explore methods for enhancing patient motivation in adhering to preventive measures.

Main Methods:

  • Development of risk functions based on classical cardiovascular risk factors in long-term cohorts (>10 years).
  • Analysis of patient risk strata to identify optimal groups for intervention (high-risk).
  • Evaluation of communication strategies (relative risk, vascular age) to improve patient compliance.

Main Results:

  • Classical risk functions are reasonably precise for coronary artery disease screening.
  • Approximately 20% of adults aged 35-74 have intermediate risk, necessitating reclassification.
  • Intermediate-risk individuals account for 35% of coronary artery disease events.
  • Biomarkers are under investigation to improve risk function precision.

Conclusions:

  • Current risk functions are valuable for primary prevention but require refinement.
  • Accurate risk communication can motivate patients towards lifestyle and drug modifications.
  • Integrating automated risk calculation into health systems can support preventive care providers.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
670
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
929
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
511
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.3K